- Home
- GALT vs MG Comparison
GALT vs MG Comparison
Compare GALT & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- MG
- Stock Information
- Founded
- GALT 2000
- MG 1978
- Country
- GALT United States
- MG United States
- Employees
- GALT N/A
- MG N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- MG Military/Government/Technical
- Sector
- GALT Health Care
- MG Consumer Discretionary
- Exchange
- GALT Nasdaq
- MG Nasdaq
- Market Cap
- GALT 232.3M
- MG 247.8M
- IPO Year
- GALT N/A
- MG 2009
- Fundamental
- Price
- GALT $3.57
- MG $9.04
- Analyst Decision
- GALT Strong Buy
- MG
- Analyst Count
- GALT 3
- MG 0
- Target Price
- GALT $6.00
- MG N/A
- AVG Volume (30 Days)
- GALT 299.1K
- MG 112.7K
- Earning Date
- GALT 08-14-2025
- MG 08-06-2025
- Dividend Yield
- GALT N/A
- MG N/A
- EPS Growth
- GALT N/A
- MG N/A
- EPS
- GALT N/A
- MG 0.37
- Revenue
- GALT N/A
- MG $702,445,000.00
- Revenue This Year
- GALT N/A
- MG $0.81
- Revenue Next Year
- GALT N/A
- MG $15.30
- P/E Ratio
- GALT N/A
- MG $24.69
- Revenue Growth
- GALT N/A
- MG N/A
- 52 Week Low
- GALT $0.73
- MG $7.06
- 52 Week High
- GALT $4.41
- MG $12.44
- Technical
- Relative Strength Index (RSI)
- GALT 58.06
- MG 68.20
- Support Level
- GALT $3.55
- MG $7.81
- Resistance Level
- GALT $3.90
- MG $9.30
- Average True Range (ATR)
- GALT 0.32
- MG 0.27
- MACD
- GALT -0.04
- MG 0.10
- Stochastic Oscillator
- GALT 41.67
- MG 83.33
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.